Hormones control essential processes like growth, metabolism, mood, and reproduction, but when their balance is disrupted, it ...

Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...

bioTheranostics, Inc's Breast Cancer Index, a genomic test quantifying the risk of breast cancer recurrence and predicting which patients will likely benefit from extended endocrine therapy, will be ...

I am Jess Bruce Assistant Manager in Transparency Market Research (TMR). TMR is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of ...

dvm360: What can [lecture] attendees learn about concurrent endocrine and dermatological disease?

Concordance and clinical impact of ER, PR, HER2 expression by local and central immunohistochemistry versus RT-PCR in HR+/HER2- early breast cancer (EBC): Results from the ADAPT trial. Rate of medical ...

Please provide your email address to receive an email when new articles are posted on . An assessment of free cortisol after a dexamethasone suppression test could add value to the diagnostic workup ...

I was struck by this large heading on an EPA website, “Rebuilding the Endocrine Disruptor Screening Program.” This program does not need to be rebuilt; it should be eliminated and consolidated with ...